Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03363217
Title Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors St. Justine's Hospital
Indications

plexiform neurofibroma

brain glioma

Therapies

Trametinib

Age Groups: adult | child
Covered Countries CAN


No variant requirements are available.